Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Toxicologic Pathology
|
April 21, 1998
Effect of chronic growth hormone administration on skeletal muscle in dogs
S Molon-Noblot, P Laroque, S Prahalada, et al.
The Prostate
|
September 1, 1995
Quantitative evaluation of glandular and stromal compartments in hyperplastic dog prostates: effect of 5-alpha reductase inhibitors
P A Laroque, S Prahalada, S Molon-Noblot, et al.
Toxicologic Pathology
|
April 21, 1998
Morphological changes in the pituitary gland of dogs chronically exposed to exogenous growth hormone
P Laroque, S Molon-Noblot, S Prahalada, et al.
Toxicologic Pathology
|
September 1, 1993
Renal papillary cytoplasmic granularity and potassium depletion induced by carbonic anhydrase inhibitors in rats
R A Owen, G Durand-Cavagna, S Molon-Noblot, et al.
The Prostate
|
January 1, 1994
Effects of chronic oral administration of a selective 5 alpha-reductase inhibitor, finasteride, on the dog prostate
P A Laroque, S Prahalada, L R Gordon, et al.
Regulatory Toxicology and Pharmacology : RTP
|
August 1, 1995
Development and submission of a nonclinical (pharmacology/toxicology) CANDA
J B Coleman, L D Wise, W P Greenberg, et al.
Teratology
|
November 1, 1992
Embryotoxicity studies of norfloxacin in cynomolgus monkeys. II. Role of progesterone
M A Cukierski, A G Hendrickx, S Prahalada, et al.
Urology
|
May 1, 1994
Qualitative and quantitative evaluation of prostatic histomorphology in rats following chronic treatment with finasteride, a 5-alpha reductase inhibitor
S R Prahalada, K P Keenan, P R Hertzog, et al.
Toxicologic Pathology
|
April 21, 1998
Pharmacological and toxicological effects of chronic porcine growth hormone administration in dogs
S Prahalada, L G Stabinski, H Y Chen, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology
|
February 1, 1994
Leydig cell hyperplasia and adenomas in mice treated with finasteride, a 5 alpha-reductase inhibitor: a possible mechanism
S Prahalada, J A Majka, K A Soper, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Toxicologic Pathology
|
April 21, 1998
Effect of chronic growth hormone administration on skeletal muscle in dogs
S Molon-Noblot, P Laroque, S Prahalada, et al.
The Prostate
|
September 1, 1995
Quantitative evaluation of glandular and stromal compartments in hyperplastic dog prostates: effect of 5-alpha reductase inhibitors
P A Laroque, S Prahalada, S Molon-Noblot, et al.
Toxicologic Pathology
|
April 21, 1998
Morphological changes in the pituitary gland of dogs chronically exposed to exogenous growth hormone
P Laroque, S Molon-Noblot, S Prahalada, et al.
Toxicologic Pathology
|
September 1, 1993
Renal papillary cytoplasmic granularity and potassium depletion induced by carbonic anhydrase inhibitors in rats
R A Owen, G Durand-Cavagna, S Molon-Noblot, et al.
The Prostate
|
January 1, 1994
Effects of chronic oral administration of a selective 5 alpha-reductase inhibitor, finasteride, on the dog prostate
P A Laroque, S Prahalada, L R Gordon, et al.
Regulatory Toxicology and Pharmacology : RTP
|
August 1, 1995
Development and submission of a nonclinical (pharmacology/toxicology) CANDA
J B Coleman, L D Wise, W P Greenberg, et al.
Teratology
|
November 1, 1992
Embryotoxicity studies of norfloxacin in cynomolgus monkeys. II. Role of progesterone
M A Cukierski, A G Hendrickx, S Prahalada, et al.
Urology
|
May 1, 1994
Qualitative and quantitative evaluation of prostatic histomorphology in rats following chronic treatment with finasteride, a 5-alpha reductase inhibitor
S R Prahalada, K P Keenan, P R Hertzog, et al.
Toxicologic Pathology
|
April 21, 1998
Pharmacological and toxicological effects of chronic porcine growth hormone administration in dogs
S Prahalada, L G Stabinski, H Y Chen, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology
|
February 1, 1994
Leydig cell hyperplasia and adenomas in mice treated with finasteride, a 5 alpha-reductase inhibitor: a possible mechanism
S Prahalada, J A Majka, K A Soper, et al.
Page
of 4